The continuing evolution of targeted therapy for inflammatory skin disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The continuing evolution of targeted therapy for inflammatory skin disease
Authors
Keywords
Biologics, Inflammation, Swarm, Combined, Phase-specific
Journal
Seminars in Immunopathology
Volume 38, Issue 1, Pages 123-133
Publisher
Springer Nature
Online
2015-09-30
DOI
10.1007/s00281-015-0524-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anakinra Improves Pyoderma Gangrenosum in Psoriatic Arthritis: A Case Report
- (2015) Marie Acquitter et al. ANNALS OF INTERNAL MEDICINE
- Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease
- (2015) Luca Cantarini et al. AUTOIMMUNITY REVIEWS
- A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone
- (2015) R.P. Hall et al. BRITISH JOURNAL OF DERMATOLOGY
- First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid
- (2015) Y.T. Cho et al. BRITISH JOURNAL OF DERMATOLOGY
- Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis
- (2015) Jamie L. Harden et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The translational revolution and use of biologics in patients with inflammatory skin diseases
- (2015) Shinji Noda et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients
- (2015) H. Vallet et al. JOURNAL OF AUTOIMMUNITY
- Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab
- (2015) Chihiro Nakayama et al. JOURNAL OF DERMATOLOGY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Perception of self: distinguishing autoimmunity from autoinflammation
- (2015) Tessa S. van Kempen et al. Nature Reviews Rheumatology
- Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab
- (2015) Yuliya Hellwig et al. PEDIATRIC BLOOD & CANCER
- IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
- (2015) Emmanuella Guenova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tocilizumab for severe refractory neuro-Behçet: Three cases IL-6 blockade in neuro-Behçet
- (2015) Olga Addimanda et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Rituximab Causing Deep Ulcerative Suppurative Vaginitis/Pyoderma Gangrenosum
- (2015) Priya Selva-Nayagam et al. Current Infectious Disease Reports
- Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma—An exclamation sign with a question mark
- (2015) Guido Kroemer et al. OncoImmunology
- Treatment of Primary Sjögren Syndrome With Rituximab
- (2014) Valérie Devauchelle-Pensec et al. ANNALS OF INTERNAL MEDICINE
- Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
- (2014) Suzana Jordan et al. ANNALS OF THE RHEUMATIC DISEASES
- Innate immune cells express IL-17A/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis
- (2014) M. Kakeda et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Intractable erosive lichen planus treated successfully with rituximab
- (2014) K. Heelan et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study
- (2014) A.J. Kanwar et al. BRITISH JOURNAL OF DERMATOLOGY
- Tocilizumab-Induced Psoriasiform Rash in Rheumatoid Arthritis
- (2014) Natalia Palmou-Fontana et al. DERMATOLOGY
- Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis
- (2014) M. A. Judson et al. EUROPEAN RESPIRATORY JOURNAL
- Rituximab in the treatment of refractory pulmonary sarcoidosis
- (2014) N. J. Sweiss et al. EUROPEAN RESPIRATORY JOURNAL
- Bullous pemphigoid occurring under anti-tumor necrosis factor-α therapy
- (2014) M. Ricci et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Infliximab in recalcitrant granuloma annulare
- (2014) Maud Amy de la Breteque et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
- (2014) Jennifer D. Hamilton et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human Th2 but Not Th9 Cells Release IL-31 in a STAT6/NF-κB–Dependent Way
- (2014) Elisabeth Maier et al. JOURNAL OF IMMUNOLOGY
- Resolution of granuloma annulare following treatment with bendamustine and rituximab in a patient with follicular lymphoma: A serendipitous finding
- (2014) BK Shah et al. Journal of Postgraduate Medicine
- Omalizumab therapy for bullous pemphigoid
- (2014) Kenneth K. Yu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Increased serum levels of interleukin 33 in patients with atopic dermatitis
- (2014) Risa Tamagawa-Mineoka et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Use of biological treatments in patients with hidradenitis suppurativa
- (2014) G. Martin-Ezquerra et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial
- (2014) Glen A Kennedy et al. LANCET ONCOLOGY
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- A case of overlap syndrome successfully treated with tocilizumab: a hopeful treatment strategy for refractory dermatomyositis?
- (2014) M. Kondo et al. RHEUMATOLOGY
- Integrative Biology Approach Identifies Cytokine Targeting Strategies for Psoriasis
- (2014) G. K. Perera et al. Science Translational Medicine
- Human TH9 Cells Are Skin-Tropic and Have Autocrine and Paracrine Proinflammatory Capacity
- (2014) C. Schlapbach et al. Science Translational Medicine
- IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants
- (2014) Andrea Saggini et al. Journal of Immunology Research
- Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
- (2013) E. M. Miloslavsky et al. ARTHRITIS AND RHEUMATISM
- Bimodal immune activation in psoriasis
- (2013) E. Christophers et al. BRITISH JOURNAL OF DERMATOLOGY
- Neutrophilic dermatoses as systemic diseases
- (2013) Lola Prat et al. CLINICS IN DERMATOLOGY
- Effectiveness of Infliximab in Pityriasis Rubra Pilaris Is Associated with Pro-Inflammatory Cytokine Inhibition
- (2013) L. Adnot-Desanlis et al. DERMATOLOGY
- Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection
- (2013) Paula Licona-Limón et al. IMMUNITY
- Refractory pemphigus foliaceus and Behçet’s disease successfully treated with tocilizumab
- (2013) Francesco Caso et al. IMMUNOLOGIC RESEARCH
- Palmoplantar subcorneal pustular dermatosis following adalimumab therapy for rheumatoid arthritis
- (2013) Maxwell B. Sauder et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- IL-9–mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation
- (2013) Jan-Eric Turner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- New Onset of Psoriasis in a Patient with Rheumatoid Arthritis Treated with Rituximab
- (2013) E. TOUSSIROT JOURNAL OF RHEUMATOLOGY
- Sarcoidosis Induced by Tocilizumab: A Paradoxical Event?
- (2013) A. NUTZ et al. JOURNAL OF RHEUMATOLOGY
- An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa
- (2013) Kieron S. Leslie et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Guidelines of care for the management of atopic dermatitis
- (2013) Lawrence F. Eichenfield et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo
- (2013) Tim Lämmermann et al. NATURE
- Activation of neutrophils by autocrine IL-17A–IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2
- (2013) Patricia R Taylor et al. NATURE IMMUNOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma
- (2013) Chad K Oh et al. RESPIRATORY RESEARCH
- Th9 cells, new players in adaptive immunity
- (2013) Edgar Schmitt et al. TRENDS IN IMMUNOLOGY
- Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
- (2012) Muriel Elhai et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful long-term triple disease control by ustekinumab in a patient with Behçet's disease, psoriasis and hidradenitis suppurativa: Table 1
- (2012) Ewout M Baerveldt et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial
- (2012) Chester V. Oddis et al. ARTHRITIS AND RHEUMATISM
- A successful treatment with ustekinumab in a case of antilaminin-γ1 pemphigoid associated with psoriasis
- (2012) Y. Majima et al. BRITISH JOURNAL OF DERMATOLOGY
- Successful Use of Interleukin 6 Antagonist Tocilizumab in a Patient With Refractory Cutaneous Lupus and Urticarial Vasculitis
- (2012) Ashima Makol et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- A Single Intradermal Injection of IFN-γ Induces an Inflammatory State in Both Non-Lesional Psoriatic and Healthy Skin
- (2012) Leanne M. Johnson-Huang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients
- (2012) R. A. Clark et al. Science Translational Medicine
- Successful Treatment of Subacute Lupus Erythematosus With Ustekinumab
- (2011) Aieska De Souza ARCHIVES OF DERMATOLOGY
- Interleukin 23 Expression in Pyoderma Gangrenosum and Targeted Therapy With Ustekinumab
- (2011) Emmanuella Guenova ARCHIVES OF DERMATOLOGY
- Efficacy of Anti-Interleukin-1 Receptor Antagonist Anakinra (Kineret®) in a Case of Refractory Sweet’s Syndrome
- (2011) Nicolas Kluger et al. DERMATOLOGY
- Contrasting pathogenesis of atopic dermatitis and psoriasis—Part II: Immune cell subsets and therapeutic concepts
- (2011) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection
- (2011) Alexander A. Navarini et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Gone but Not Forgotten: Lesional Memory in Psoriatic Skin
- (2011) Rachael A. Clark JOURNAL OF INVESTIGATIVE DERMATOLOGY
- T-bet in disease
- (2011) Vanja Lazarevic et al. NATURE IMMUNOLOGY
- An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation
- (2011) Christoph Wilhelm et al. NATURE IMMUNOLOGY
- Mutual Antagonism of T Cells Causing Psoriasis and Atopic Eczema
- (2011) Stefanie Eyerich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Tumor Necrosis Factor-α Treatment with Infliximab for Disseminated Granuloma Annulare
- (2010) Giuseppe Murdaca et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- LICHEN PLANUS ASSOCIATED WITH OMALIZUMAB ADMINISTRATION IN AN ADULT WITH ALLERGIC ASTHMA
- (2010) Filiz O. Seeborg et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Atopic Dermatitis
- (2010) Thomas Bieber Annals of Dermatology
- Treatment of pityriasis rubra pilaris with ustekinumab
- (2010) J. Wohlrab et al. BRITISH JOURNAL OF DERMATOLOGY
- A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study
- (2010) D. Thaçi et al. BRITISH JOURNAL OF DERMATOLOGY
- Control of Widespread Hypertrophic Lupus Erythematosus with T-Cell-Directed Biologic Efalizumab
- (2010) Alexander A. Navarini et al. DERMATOLOGY
- Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent
- (2010) Sreedhar Subramanian et al. INFLAMMATORY BOWEL DISEASES
- Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)
- (2010) Fereydoun DAVATCHI et al. International Journal of Rheumatic Diseases
- Severe pyoderma gangrenosum unresponsive to etanercept and adalimumab
- (2010) Marloes M. Kleinpenning et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Biologic Therapy for Systemic Sclerosis: A Systematic Review
- (2010) V. PHUMETHUM et al. JOURNAL OF RHEUMATOLOGY
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
- (2010) Y. Shima et al. RHEUMATOLOGY
- Alefacept for Severe Alopecia Areata
- (2009) Bruce E. Strober et al. ARCHIVES OF DERMATOLOGY
- A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease
- (2009) Daniel R. Couriel et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra
- (2009) M. Brenner et al. BRITISH JOURNAL OF DERMATOLOGY
- Bullous Pemphigoid Occurring during Efalizumab Treatment for Psoriasis: A Paradoxical Auto-Immune Reaction?
- (2009) Karine Monnier-Murina et al. DERMATOLOGY
- Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
- (2009) Caroline E. Sutton et al. IMMUNITY
- Using N-of-1 Trials in Evidence-Based Clinical Practice
- (2009) Apostolos Tsapas JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- IL-33–activated dendritic cells induce an atypical TH2-type response
- (2009) Matthew A. Rank et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lichen planus–like eruptions: An emerging side effect of tumor necrosis factor-α antagonists
- (2009) Adam Asarch et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efalizumab for severe refractory atopic eczema: retrospective study on 11 cases
- (2009) K Ibler et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lack of efficacy of etanercept in Sjogren syndrome correlates with failed suppression of tumour necrosis factor and systemic immune activation
- (2008) N M Moutsopoulos et al. ANNALS OF THE RHEUMATIC DISEASES
- New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra
- (2008) M.A. González-López et al. BRITISH JOURNAL OF DERMATOLOGY
- Anti-CD20 (rituximab) treatment improves atopic eczema
- (2008) Dagmar Simon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Alefacept for moderate to severe atopic dermatitis: A pilot study in adults
- (2008) Danielle K. Moul et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Subcutaneous efalizumab is not effective in the treatment of alopecia areata
- (2008) Vera H. Price et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum
- (2008) CE Foss et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Development of familial benign chronic pemphigus in a patient undergoing treatment with efalizumab for psoriasis
- (2008) J Santos-Juanes et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis
- (2008) P. Riley et al. RHEUMATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started